The stock market has been racing higher at nearly unprecedented levels in recent years. Even so, the healthcare sector in general, and biopharma stocks in particular, have still managed to crush the broader markets over the last few years. Since 2012, for instance, the iShares Nasdaq Biotech Index (NASDAQ: IBB ) has more than tripled the returns of the closely watched S&P 500.
Perhaps what's surprising is that even dividend paying Big Pharma stocks, like Eli Lilly (NYSE: LLY), Johnson & Johnson (NYSE: JNJ), and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), have soared since 2012. Put simply, these "income stocks" have been behaving more like "growth stocks" throughout the course of this incredible bull run. The growth party, though, might be coming to a swift end. According to the 13F filings with the SEC during the third-quarter, we learned that a number of major hedge funds, such as Soros Fund Management, have begun dumping these three top dividend stocks. Specifically, the Soros Fund sold its entire position in both Lilly and J&J, and a noteworthy 14.3% of its massive Teva holdings during the third-quarter.
Source: Motley Fool
Related Articles:
- If Only I Had Known About These Dividend Stocks...
- 10 Dividend Stocks Delivering The Secret To Success
- 10 Dividend Stocks For A Rainy Day
- 4 Higher Yielding Basic Materials Stocks With Growing Dividends
- 7 Dividend Growth Stocks That Could Make You Wealthy
George Soros Is Dumping These 3 Dividend Stocks: Should You?
Posted by D4L | Tuesday, December 30, 2014 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
~
Popular Posts Last 30 Days
-
Long-term investors know that dividends can have a major impact on returns over time. When the stock market is struggling to make gains like...
-
As a relatively new blogger, the one thing that has stood out in my mind is the number of Canadian bloggers in the areas that I am most inte...
-
We decided to go on a hunt for quality stocks that for one reason or another have been buried, and not just this year. We found three incred...
-
Buy and hold ... forever? It's a tall order, but a select few companies are potentially up to the task. You can build a wealth-compoundi...
-
Does the high interest rate environment we're living in have you feeling down? Here's something to remember that can help you turn t...
-
Dividend stocks can be consistent market-beaters. However, empirical research shows that the best dividend stocks tend to generate better-th...
-
High-quality dividend stocks are always worth loading up on. This is doubly true for companies that offer shareholders an attractive mix of ...
-
Some dividend-paying companies have seen their financials struggle over the years. These companies become vulnerable to dividend cuts which ...
-
Essentially, we’re looking for more Apples – tech firms with a large market cap (at least $1-billion) and the financial means necessary to p...
-
Numerous high-quality dividend opportunities are up for grabs at the moment, which may be appealing to some investors given the uncertainty ...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.